Clinical trials
Completed Phase 2 Carcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
97 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2002 | 10 |
| 2003 | 3 |
| 2004 | 1 |
| 2005 | 10 |
| 2006 | 10 |
| 2007 | 4 |
| 2008 | 9 |
| 2009 | 9 |
| 2010 | 5 |
| 2011 | 5 |
| 2012 | 4 |
| 2014 | 2 |
| 2015 | 4 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 97 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 12 |
| Eli Lilly and Company | 8 |
| Pfizer | 6 |
| Amgen | 4 |
| H. Lee Moffitt Cancer Center and Research Institute | 4 |
| Oncolytics Biotech | 3 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 3 |
| Sunesis Pharmaceuticals | 3 |
| University of Chicago | 3 |
| Merck KGaA, Darmstadt, Germany | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma | 97 |
| Neoplasms | 39 |
| Neoplasm Metastasis | 18 |
| Carcinoma, Non-Small-Cell Lung | 17 |
| Lung Neoplasms | 9 |
| Adenocarcinoma | 8 |
| Head and Neck Neoplasms | 8 |
| Neoplasms by Site | 8 |
| Ovarian Neoplasms | 8 |
| Pancreatic Neoplasms | 8 |
Trials
Showing 1 to 25 of 97. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.